Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - micafungin sodium - powder for solution for infusion - 100mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - micafungin sodium - powder for solution for infusion - 100mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - micafungin sodium - powder for solution for infusion - 100mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - micafungin sodium - powder for solution for infusion - 100mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - micafungin sodium - powder for solution for infusion - 100mg

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

apotex corp. - micafungin (unii: r10h71bswg) (micafungin - unii:r10h71bswg) - micafungin for injection is indicated for: - treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses in adult and pediatric patients 4 months of age and older [see clinical studies (14.1) and use in specific populations (8.4)] - treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses without  meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see use in specific populations (8.4)] . - treatment of esophageal candidiasis in adult and pediatric patients 4 months of age and older [see clinical studies (14.2)] . - prophylaxis of candida infections in adult and pediatric patients 4 months of age and older undergoing hematopoietic stem cell transplantation [see clinical studies (14.3)].   limitations of use - the safety and effectiveness of micafungin for injection has not   been established for the treatment of candidemia with   meningoencephalitis and/or ocular dissemination in pediatric patien

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

par pharmaceutical, inc. - micafungin sodium (unii: is1up79r56) (micafungin - unii:r10h71bswg) - micafungin for injection is indicated for: - treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses in adult and pediatric patients 4 months of age and older [see clinical studies (14.1) and use in specific populations (8.4)] treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses in adult and pediatric patients 4 months of age and older [see clinical studies (14.1) and use in specific populations (8.4)] - treatment of esophageal candidiasis in adult and pediatric patients 4 months of age and older[see clinical studies (14.2)] . - prophylaxis of candida infections in adult and pediatric patients 4 months of age and older undergoing hematopoietic stem cell transplantation [see clinical studies (14.3)] prophylaxis of candida infections in adult and pediatric patients 4 months of age and older undergoing hematopoietic stem cell transplantation [see clinical studies (14.3)] limitations of use - micafungin for injection has not been ade

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - micafungin - powder for concentrate for solution for infusion - 50 milligram(s) - micafungin

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

astellas pharma ltd - micafungin sodium - powder for solution for infusion - 100mg

Malta - angielski - Medicines Authority

cz pharma s.r.o. námìstí smiøických 42, 281 63 kostelec kostelec nad cernými lesy,, czech republic - micafungin sodium - powder for concentrate for solution for infusion - micafungin sodium 100 mg - antimycotics for systemic use